ReWalk機器人技術 RWLK 深 滬
等待開盤 09-23 09:30:00 美东时间
1.0501
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.0501
- 總市值 6.29万
- 52周最高 109.20
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 47.0736
- 委 比 0.00%
- 總股本 5.99万
- 歷史最高 91782.60
- 量 比 0
- 振 幅 0.00%
- 歷史最低 34.44
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lifeward Announces Publication Of Researcher-Led Peer-Reviewed Study Showing Potential For Individuals With Chronic Spinal Cord Injury To Use Personal Exoskeleton To Perform Everyday Activities
Landmark independent study reports significantly improved task performance and satisfaction and lower pain compared with wheelchair use ReWalk users with chronic spinal cord injury were able to perform everyday kitchen and grooming activities while standing with a personal exoskeleton Publication a...
09-15 20:05
Lifeward Launches Six-Mointh Pilot Program With Ottobock Care To Enable Greater Patient Access To Its ReWalk 7 Personal Exoskeleton
The agreement brings together Lifeward’s advanced personal exoskeleton technology and Ottobock Care’s established clinical expertise and regional patient care infrastructure. Through the pilot, the companies intend to increase awareness of ReWalk 7 among rehabilitation hospitals and spinal cord inju...
08-05 20:04
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
Lifeward, a biomedical innovation company, has launched a six-month pilot program with Ottobock Care to expand access to the ReWalk 7 Personal Exoskeleton. Ottobock Care, a leading U.S. mobility technology patient care organization, brings clinical expertise and infrastructure to support patient access and training. The partnership aims to increase awareness of ReWalk 7 among rehabilitation hospitals and spinal cord injury centers, while building...
08-05 12:00
2026年全球外骨骼机器人行业发展现状 动力下肢主导，行业处于商业化起步阶段【组图】
登录新浪财经APP 搜索【信披】查看更多考评等级 转自：前瞻产业研究院 行业主要上市公司：机器人（300024）、伟思医疗（688580）、美...
07-29 13:00
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
Lifeward Ltd. (Nasdaq: LFWD) has secured an initial $5.6 million in senior secured convertible notes and warrants, with an additional $5.6 million available upon achieving specific commercial milestones, including a 150% increase in ReWalk® unit sales or its shares trading at $13.80 for ten consecutive days. This financing aims to accelerate the commercialization of its restorative healthcare platform, expand its reimbursement-backed distribution...
07-07 20:15
Lifeward Q1营收不及预期，战略转型费用拖累盈利
核心财务数据 Lifeward公布2026年第一季度财报。公司报告期内营收为392万美元，同比下降22.1%，低于市场预期的578万美元。非GAAP每股...
05-15 23:52
Lifeward Q1 2026 Earnings Call Transcript
Lifeward (NASDAQ:LFWD) reported first-quarter financial results on Friday. The ...
05-15 21:10
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
Lifeward Ltd. announced it will report its Q1 2026 financial results before U.S. markets open on May 15, 2026. A conference call and live webcast will follow at 8:30 a.m. EDT, hosted by Mark Grant, President and CEO, and Almog Adar, CFO. The call can be accessed via toll-free and international numbers, with an access code referencing the "Lifeward Earnings Call." A live webcast and archived version will be available on the Company’s website. Life...
05-11 13:25
Lifeward Successfully Closes on Strategic Partnership with Oramed
Lifeward Ltd. announced the closure of its strategic partnership with Oramed Pharmaceuticals Inc., acquiring Oramed's POD™ technology and securing up to $47 million in capital, with $10 million accessed. The partnership aims to diversify Lifeward's biomedical portfolio and enhance profitability, supporting its mission to innovate for individuals with physical limitations.
03-25 20:10
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
Lifeward Ltd. has regained compliance with Nasdaq's minimum bid price requirement, maintaining a closing bid of $1.00 or higher for 10 consecutive days, ensuring continued listing on the Nasdaq Capital Market. The company, a leader in medical technology, focuses on innovative solutions for physical rehabilitation and recovery, including the ReWalk Exoskeleton and AlterG Anti-Gravity System.
03-11 12:00
